M. Migita

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.

A Tominaga, N. Koyama, Shigeki Katoh et al. · The Journal of Experimental Medicine · 1991 · 297 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +18

Molecular cloning and expression of the human interleukin 5 receptor.

Yoshiyuki Murata, M. Migita, Yukiko Kikuchi et al. · The Journal of Experimental Medicine · 1992 · 199 citations · Full text

Inflammation, Cytokine, Molecular Immunology +14

A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Akira Shirahata, Katsuyuki Fukutake, Junki Takamatsu et al. · Haemophilia · 2013 · 29 citations

A phase <scp>III</scp> clinical trial of a mixture agent of plasma‐derived factor <scp>VII</scp>a and factor X (<scp>MC</scp>710) in haemophilia patients with inhibitors

Yuichi Shinkoda, Akira Shirahata, Katsuyuki Fukutake et al. · Haemophilia · 2016 · 28 citations

Depressed natural killer cell activity due to decreased natural killer cell population in a vitamin E-deficient patient with Shwachman syndrome: reversible natural killer cell abnormality by α-tocopherol supplementation

Naoto Adachi, M. Migita, T. Ohta et al. · European Journal of Pediatrics · 1997 · 23 citations

Immunodeficiencies, Immunology, Shwachman Syndrome +5